entertainment -WSS

entertainment

author：knowledge 2025-10-02 05:38:20 - browse：5

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Baby aspirin cuts fat buildup in liver disease patients, in small study

WSS

Baby aspirin cuts fat buildup in liver disease patients, in small study

Petition to FDA: Get the lead out of consumer hair dyes

Readout Newsletter: Bluebird, CVS, Contineum

Baby aspirin cuts fat buildup in liver disease patients, in small study

Beach reads and more: STAT's 2023 summer book list

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

knowledge

entertainment

focus

Trump demands the U.S. pay no more for drugs than other countries … again

It's time to get medical device identifiers over the finish line

Anesthesiologist group: stop taking Ozempic before surgery

What to know about OceanGate, the company behind the missing Titanic submersible

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

What does generative AI mean for health care? We asked experts

California’s proposed $25 per hour health care minimum wage

State Dept. review finds Biden bears some blame for Afghanistan failures

Future doctors should be trained to promote social change

knowledge

HCA discloses massive data breach affecting 11 million patients

How the political right came to back psychedelics to treat trauma

It's time to get medical device identifiers over the finish line

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Physicians and social media: If you see something, say something?

Health AI adoption puts security, privacy startups on investors' radar

hotspot

focus

focus

knowledge